SEP 17, 2015 9:44 AM PDT

Enabling the Innate Immune System to Fight Cancer

WRITTEN BY: Kara Marker
Cancer immunotherapy efforts have been mainly concentrated on the adaptive immune system, some even connecting epigenetic therapy and immunotherapy to prevent cancer cells from blocking activation of T cells. Today, a promising new study in the journal Immunity shares promising results of experiments focused on the innate immune system and its role in the fight against cancer.

What if we could help the body fight cancer all on its own, instead of pumping the body full of chemicals?
Focusing on the adaptive immune system makes cancer treatments more difficult to develop due to the specificity of T cells, B cells, antibodies, and their targets. Each cancer type and patient cancer case could potentially need a unique treatment of immunotherapy if manipulating the adaptive immune system. Dr. Maya Saleh, leader of the study published in Immunity and professor at McGill University, describes the more general, possibly quicker action of enabling the immune system to detect and fight cancer: innate immune cells "broadly survey tissues for the presence of 'danger' signals." The key word here is "broadly." 

In the study, Saleh and her team looked at experimental and control mice with colorectal cancer to determine the impact of cancer growth and spread. Some mice had impaired immune systems, and results showed that mice with unimpaired immune systems had less cancer growth and spread. Saleh's team was also able to identify specific innate immune cells that were active in preventing cancer growth.

NLRP3, a gene that codes for the production of cryopyrin protein, regulates the innate immune response to injury and invasion and also engages other immune cells (U.S. National Library of Medicine). In their study with colorectal cancer mice, Saleh's team saw NLRP3 act as a sensor that activated an effector cytokine, Interleukin 18. According to the National Center for Biotechnology Information, IL-18 is a proinflammatory cytokine that instigates natural killer (NK) cells activity. Saleh's team found the same action in the mice study. NK cells are innate lymphocytes that recognize abnormal cells (Nature). Cancer cells definitely fit under the definition of "abnormal" - seeing as they grow uncontrollably and irregularly. 

Now that this team from McGill University has demonstrated the potential of the innate immune system to target cancer cells and inhibit their growth and spread in the body, the options for therapeutics are many. Harnessing this ability of the innate immune system will be a paramount next step in the fight against cancer.

Check out the following Nature video to hear and see a great overview of current cancer immunotherapies.


Sources: Medical Xpress and McGill University
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 16, 2019
Immunology
OCT 16, 2019
Coffee Bean Extracts for Fat-induced Inflammation
One man’s coffee trash is another man’s solution for addressing chronic inflammation. A new Food and Chemical Toxicology study illustrates the ...
OCT 29, 2019
Immunology
OCT 29, 2019
Immune Protein Prevents Herpes Spreading to the Brain
An immune protein that was discovered more than two decades ago has been identified as the primary component of a molecular blockade that prevents genital ...
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 31, 2019
Genetics & Genomics
DEC 31, 2019
Should the Scientist Behind World's First Gene Edited Babies be in Prison?
He Jiankui, the scientist behind the world’s first gene-edited babies in 2018, has been sentenced to three years in prison by Chinese authorities for...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
Loading Comments...